India: Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid®) - Khurana and Khurana
On the other hand, all Hatch-Waxman litigation between Sun Pharma and Celgene, regarding the Revlimid patents will be dismissed.
Full Article